Caporali, Roberto, Roberto Ravasio, Paola Raimondo, and Fausto Salaffi. “Cost Per Responder for Upadacitinib Vs Abatacept in Patients With Moderate-to-Severe Rheumatoid Arthritis in Italy”. Global and Regional Health Technology Assessment 8, no. 1 (July 12, 2021): 69–79. Accessed April 20, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/2267.